CMD in in Ke Kenya ya Were, HK 1 , Ememwa I 1 , Wabwile MW 1 , - - PowerPoint PPT Presentation

cmd in in ke kenya ya
SMART_READER_LITE
LIVE PREVIEW

CMD in in Ke Kenya ya Were, HK 1 , Ememwa I 1 , Wabwile MW 1 , - - PowerPoint PPT Presentation

Eva valua uation tion of f Tra ransform sformed ed cas assav ava a Li Lines es fo for r Resistance stance to CBSD SD an and CMD in in Ke Kenya ya Were, HK 1 , Ememwa I 1 , Wabwile MW 1 , Were MN 1 ,Vernderschuren H 2 and


slide-1
SLIDE 1

Were HK PhD 1

Eva valua uation tion of f Tra ransform sformed ed cas assav ava a Li Lines es fo for r Resistance stance to CBSD SD an and CMD in in Ke Kenya ya

 1 Department of Biological Sciences, Masinde Muliro University of

Science and Technology, P.O. Box 190, 50100 Kakamega, Kenya.

 2 Department of Biology and Plant Biotechnology, ETH Zurich,

Universitaetstrasse 2, 8092 Zurich Switzerland

6th Annual National Biosafety Conference, KSMS 3rd - 6th October, 2017

Were, HK1, Ememwa I1, Wabwile MW1, Were MN1,Vernderschuren H2 and Gruissem W2

slide-2
SLIDE 2

Were HK PhD 2

 Cassava (Mannihot esculenta Crantz) is

starchy, tuberous root crop

 Is grown mainly in western Kenya (including Kakamega,

Bungoma, Busia, Homa Bay, Siaya, Kisii, Migori Makueni, Kilifi and Kwale counties

 It is usually grown in rain fed, low-input systems and the

yields obtained in Kenya of 4 t/ha are among the poorest in the world

 Although traditionally regarded as a subsistence crop,

cassava is increasingly being produced for commercial purposes

slide-3
SLIDE 3

Were HK PhD 3

slide-4
SLIDE 4

 Pests and diseases are major problems:

  • Cassava Mosaic Disease (CMD)
  • Cassava brown streak disease (CBSV)
  • Cassava Bacterial blight (Xanthomonas axonopodis PV

manihotis)

  • Cassava anthracnose (Colletotrichum gloeosporoides

f.sp manihotis)

 Inadequate or Lack of high quality disease-free

planting material in the form of ‘seed’ cuttings

 Low soil fertility and poor agronomic practices

Were HK PhD 4

slide-5
SLIDE 5

Were HK PhD 5

Symptoms of CBSD and CMD

slide-6
SLIDE 6

diseased healthy

slide-7
SLIDE 7
slide-8
SLIDE 8

 Two viral diseases: (ACMV, a DNA virus) and (CBSV,

an RNA virus), often resulting in total loss of starchy root yield

 Breeding for resistance is difficult, time-consuming

and often not durable

 So far no natural resistance to CBSV  Genetic engineering may stand a chance?

slide-9
SLIDE 9

 Line TME 7-has natural resistance against CMD  Line 60444-has some tolerance to CBSD  Virus resistance can be achieved by expression of

inverted repeat sequences coding for hairpin double-stranded RNAs homologous to viral sequences.

 The hairpin RNAs target viral sequences for

degradation and/or modifications.

 Such small RNAs homologous to viruses do

accumulate in wild-type cassava under natural infection (Akbergenov et al., 2006).

Were HK PhD 9

slide-10
SLIDE 10

 Develop cassava that is resistant to both CMD

and CBSD using replicase and RNAi technology (genetic engineering)

 Evaluate the engineered clones in the glass

house and in the Field for resistance to the viruses

Were HK PhD 10

slide-11
SLIDE 11

 Friable embryogenic callus (FEC) generated according

to (Bull et al., 2009; Zainuddin et al., 2012)

 FEC genetically transformed with Agrobacterium

tumefasciens LBA4404 carrying the binary vectors for transformation.

 Line TME 7-engineered for resistance to CBSD  Line 60444-engineered for resistance to CMD  Transgenic cassava lines regenerated from transformed

FEC following established procedures (Zhang et al., 2000; Bull et al., 2009; Zainuddin et al., 2012)

Were HK PhD 11

slide-12
SLIDE 12

Were HK PhD 12

 Regenerated transformed cassava plantlets

hardened in the glass house for 60 days

 Scions from transgenic cassava grafted on

diseased cassava rootstocks in the greenhouse

 Through greenhouse inoculation assays, the

transgenic cultivars remained resistant in successive planting cycles

WHAT WE DID . . . . . . . . . . . .2

slide-13
SLIDE 13

Were HK PhD 13

Transformed cassava in glass house In tissue culture In the CFT In the lab

slide-14
SLIDE 14

Were HK PhD 14

Transgenic cassava growing at Alupe CFT

slide-15
SLIDE 15

Line Description of event Mean % CMD incidence Mean tuber count (No.) Mean Tuber weight (kg) 74 ds CR-2 93 2 0.1 133 ds ACI-152 76 3 0.3 157 ds ACI ds AVI-113 94 9 0.5 167 double single 53 59 8 0.8 145 ds ACI ds AVI-59 20 27 0.7 348 Pc 1301 -2k 85 5 0.6 30 60444 82 6 0.4 115 ds ACI-2 75 7 0.5 129 ds ACI-101 54 5 0.9 137 ds ACI ds AVI-7 76 5 0.5 141 ds ACI ds AVI-55 79 5 0.5 166 double single 52 71 7 0.9

slide-16
SLIDE 16
  • Six lines (19, 402, 407, 501, 506 and 30) had both

foliage and root symptoms

  • Nine lines (22, 56, 398.401,404, 406,497 and 498,

499) had only root symptoms

  • Lines 405 and 506 had neither root nor foliar

symptoms

16

slide-17
SLIDE 17

 Two lines (405 and 506) show promising

response towards CBSD resistance

 Inserting a construct in TME line breaks CMD

resistance

 Not yet clear if we have CMD resistance in the

plants

Were HK PhD 17

slide-18
SLIDE 18

129 129 348 348 141 141 145 145 167 167 LAD ADDER ER ds c close circul ular ssDNA NA ds o

  • pen

n circul ular ar

slide-19
SLIDE 19

30 12 9 141 145 133 167 166 137 30 30 12 9 129 141 141 145 145 133 16 7 167 166 166 137 137 348 348 Ladder

SOU OUTHERN HERN BLOT OT WITH H AN ENDOG OGENO ENOUS US PROB OBE (LOA OADING DING CON ONTROL) OL)

slide-20
SLIDE 20

3021.25 1401.878 1853.11 4697.736 664.2388 167.466 1494.076 12 500 1000 1500 2000 2500 3000 3500 4000 4500 5000 60444 129 133 167 348 166 137 q

CMV TITRE qPCR

PP2A CMV(all) F-GGTCCTGGATTGCAGAGGAAGATAGTGGG R-GGTACAAACGTCATTGATGACGTCGATCCC

qPCR RESULTS

slide-21
SLIDE 21

1.98542 98542966 9667 0.9108545 9108545 0.798935 798935 0.2134818 2134818 1.4913673 491367333 8.1667445 1667445 1.32005 32005 1.347841 347841 0.357682 357682 0.025519 025519 1 2 3 4 5 6 7 8 9 6044 60444 401 401 501 501 506 506 402 402 407 407 499 499 406 406 PS PSTV TV NEGV

CBSV TITRE (qPCR)

slide-22
SLIDE 22

30 141 145 133 167 166 137 30 30 12 9 129 141 141 145 145 133 16 7 167 166 166 137 137 +

  • 91% of the samples tested were EACMV positive
slide-23
SLIDE 23

30 12 9 141 145 133 167 166 137 30 30 12 9 129 141 141 145 145 133 16 7 167 166 166 137 137 + Ladder 133 75%-ACMV positive 2/3 sample negative in lines 129,166 and 167

slide-24
SLIDE 24

 Mixed ACMV-EACMV infection in 62% of the samples

tested

 72% of the ACMV positive samples tested positive for

ACMV-Ug Severe

 61% positive for ACMV-Ug 34  86% of the EACMV positive samples were positive for

EACMV-UG

 None of the samples was positive EACMV-TZ and

EACMV-Ke

 UCBSV was more prevalent (82%) than CBSV (67%)  Most samples had mixed infections of CBSV and

UCBSV

 The viruses EACMV-TZ, EACMCV, EACMNV,

EACMKV and EACMZV were not detected

slide-25
SLIDE 25

 For CMD, Lines 129 and 166 show some tolerance  Most lines infected by more than one virus species

(high virus titres)

 High disease and vector pressure in W Kenya  For CBSD, lines 405 and 506 showed some

resistance and need to be investigated further

 Both CBSD and UCBSV occur in Western Kenya

25

slide-26
SLIDE 26

Were HK PhD 26

slide-27
SLIDE 27

Were HK PhD 27

slide-28
SLIDE 28

 Financial support was provided by ETH-Zurich  Work done in collaboration with Prof. Wilhelm

Gruissem, ETH-Zurich

 NBA

Were HK PhD 28

slide-29
SLIDE 29

Were HK PhD 29